Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 277-283

  Fox, Amy M ^a,c   Dosoretz, Arie P ^a,d   Mauch, Peter M ^a   Chen, Yu Hui ^b   Fisher, David C ^b   Lacasce, Ann S ^b   Freedman, Arnold S ^b   Silver, Barbara ^a   Ng, Andrea K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c 21ST CENTURY ONCOLOGY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hodgkin lymphoma; Mean lung dose; Pulmonary toxicity; Radiation pneumonitis

Indexed keywords

FISHER EXACT TEST; HODGKIN LYMPHOMA; MEAN LUNG DOSE; PREDICTIVE FACTORS; PULMONARY TOXICITY; RADIATION PNEUMONITIS; RADIATION THERAPY ONCOLOGY GROUPS;

ONCOLOGY; RADIOTHERAPY;

BIOLOGICAL ORGANS;

BLEOMYCIN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; NAVELBINE; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; DISEASE SEVERITY; DOSIMETRY; FEMALE; HODGKIN DISEASE; HUMAN; LUNG; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MORBIDITY; MULTIMODALITY CANCER THERAPY; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; RADIATION HAZARD; RADIATION PNEUMONIA; RISK ASSESSMENT; SCORING SYSTEM; STEM CELL TRANSPLANTATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARBOPLATIN; COMBINED MODALITY THERAPY; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FEMALE; HODGKIN DISEASE; HUMANS; IFOSFAMIDE; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RECURRENCE; RISK ASSESSMENT; VINBLASTINE; YOUNG ADULT;

EID: 84859872979     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.05.078     Document Type: Article

References (29)

1. N.J. Tarbell, L. Thompson, and P. Mauch Thoracic irradiation in Hodgkin's disease: Disease control and long-term complications Int J Radiat Oncol Biol Phys 18 1990 275 281
2. C. Hua, K.A. Hoth, and S. Wu Incidence and correlates of radiation pneumonitis in pediatric patients with partial lung irradiation Int J Radiat Oncol Biol Phys 78 2010 143 149
3. E.S. Koh, A. Sun, and T.H. Tran Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma Int J Radiat Oncol Biol Phys 66 2006 223 228
4. T. Libera, R. Mucke, and S. Cihal Influence of reduction of radiation dosage on the incidence of radiation-induced pneumonitis, pulmonary fibrosis and pericarditis after mediastinal irradiation in the treatment of lymphogranulomatosis Strahlenther Onkol 173 1997 330 334
5. D.L. Longo, E. Glatstein, and P.L. Duffey Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease J Clin Oncol 15 1997 3338 3346
6. S. Sleijfer Bleomycin-induced pneumonitis Chest 120 2001 617 624
7. P. Brice, J. Tredaniel, and J.J. Monsuez Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin's disease Ann Oncol 2 Suppl. 2 1991 73 76
8. A. Hirsch, N. Vander Els, and D.J. Straus Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease J Clin Oncol 14 1996 1297 1305
9. S.J. Horning, A. Adhikari, and N. Rizk Effect of treatment for Hodgkin's disease on pulmonary function: Results of a prospective study J Clin Oncol 12 1994 297 305
10. R.W. Tsang, M.K. Gospodarowicz, and S.B. Sutcliffe Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease. PMH Lymphoma Group, and the Toronto Autologous BMT Group Eur J Cancer 35 1999 73 78
11. F. Villani, S. Viviani, and V. Bonfante Late pulmonary effects in favorable stage I and IIA Hodgkin's disease treated with radiotherapy alone Am J Clin Oncol 23 2000 18 21
12. H. Eghbali, F. Bonichon, and B. David Combination of ABVD and radiotherapy in early stages of Hodgkin's disease: Analysis of a series of 94 patients. Pierre and Marie Curie Group (GPMC) Radiother Oncol 18 1990 127 136
13. S.J. Horning, R.T. Hoppe, and S.L. Hancock Vinblastine, bleomycin, and methotrexate: An effective adjuvant in favorable Hodgkin's disease J Clin Oncol 6 1988 1822 1831
14. A. Macann, H. Bredenfeld, and R.P. Muller Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen: A report by the German Hodgkin's Lymphoma Study Group Int J Radiat Oncol Biol Phys 70 2008 161 165
15. M. Benekli, S.L. Smiley, and T. Younis Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma Bone Marrow Transplant 41 2008 613 619
16. S. Lonial, T.W. Jones, and S. Devine High dose chemotherapy without hematopoietic cell support for the treatment of refractory lymphoma Leuk Lymphoma 36 2000 497 502
17. M.J. Stuart, N.S. Chao, and S.J. Horning Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease Biol Blood Marrow Transplant 7 2001 552 560
18. J. Yahalom, S.C. Gulati, and M. Toia Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease J Clin Oncol 11 1993 1062 1070
19. C.H. Moskowitz, T. Kewalramani, and S.D. Nimer Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease Br J Haematol 124 2004 645 652
20. C.H. Moskowitz, S.D. Nimer, and A.D. Zelenetz A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: Analysis by intent to treat and development of a prognostic model Blood 97 2001 616 623
21. D.C. Weber, N. Peguret, and G. Dipasquale Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: A comparative planning study Int J Radiat Oncol Biol Phys 75 2009 1578 1586
22. S. Senan, A. Piet, and F. Lagerwaard Involved-node radiotherapy to the mediastinum Radiother Oncol 82 2007 108 109 author reply 109-110
23. T. Girinsky, R. van der Maazen, and L. Specht Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines Radiother Oncol 79 2006 270 277
24. K.A. Goodman, S. Toner, and M. Hunt Intensity-modulated radiotherapy for lymphoma involving the mediastinum Int J Radiat Oncol Biol Phys 62 2005 198 206
25. J. Yahalom Transformation in the use of radiation therapy of Hodgkin lymphoma: New concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT) Eur J Haematol Suppl 2005 90 97
26. T. Girinsky, C. Pichenot, and A. Beaudre Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes? Int J Radiat Oncol Biol Phys 64 2006 218 226
27. M. Ghalibafian, A. Beaudre, and T. Girinsky Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: Dose constraints to virtual volumes or to organs at risk? Radiother Oncol 87 2008 82 88
28. B.S. Chera, C. Rodriguez, and C.G. Morris Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: Conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy Int J Radiat Oncol Biol Phys 75 2009 1173 1180
29. L. Cella, R. Liuzzi, and M. Magliulo Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques Radiat Oncol 5 2010 33